	Capital Social Ordinario		Fecha
Abbott	USD 1.74B	23.39B	2025-09
Acadia Pharmaceuticals	USD 168.71M	104K	2025-09
Agios Pharmaceuticals	USD 58.28M	241K	2025-09
Akebia Therapeutics	USD 2K	0	2025-03
Alnylam Pharmaceuticals	USD 131.79M	130.49M	2025-09
AstraZeneca	USD 1.55B	206K	2025-12
BioMarin Pharmaceutical	USD 192.1M	97K	2025-09
Coherus Biosciences	USD 12K	0	2025-03
Eli Lilly	USD 946.83M	354.23M	2025-06
Esperion Therapeutics	USD 112K	11K	2023-09
Halozyme Therapeutics	USD 117.52M	98K	2025-09
Illumina	USD 152.8M	900K	2025-12
Insmed	USD 212.58M	210.76M	2025-09
Ironwood Pharmaceuticals	USD 160K	0	2024-12
J&J	USD 2.41B	584K	2025-09
MacroGenics	USD 63.26M	62.63M	2025-09
MannKind	USD 307.03M	303.99M	2025-09
Merck	USD 2.49B	15.79M	2025-09
Moderna	USD 391M	2M	2025-09
Novartis	USD 1.94B	23.4M	2025-06
PTC Therapeutics	USD 79.93M	554K	2025-09
Puma Biotechnology	USD 5K	0	2024-06
Sarepta Therapeutics	USD 104.77M	7.06M	2025-09
Thermo Fisher Scientific	USD 375.71M	1.9M	2025-12
Ultragenyx Pharmaceutical	USD 96.44M	88K	2025-09
United Therapeutics	USD 42.9M	42.1M	2025-09
Vanda Pharmaceuticals	USD 58K	0	2024-12

Lexicon Pharmaceuticals Capital Social Ordinario - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.